Haverford Trust Company’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $552K | Buy |
26,898
+150
| +0.6% | +$3.43K | ﹤0.01% | 295 |
|
|
2026
Q1 | $589K | Hold |
26,748
| – | – | 0.01% | 278 |
|
|
2025
Q4 | $315K | Hold |
26,748
| – | – | ﹤0.01% | 356 |
|
|
2025
Q3 | $424K | Sell |
26,748
-25
| -0.1% | -$363 | ﹤0.01% | 308 |
|
|
2025
Q2 | $307K | Sell |
26,773
-10,538
| -28% | -$119K | ﹤0.01% | 355 |
|
|
2025
Q1 | $505K | Hold |
37,311
| – | – | 0.01% | 284 |
|
|
2024
Q4 | $631K | Hold |
37,311
| – | – | 0.01% | 259 |
|
|
2024
Q3 | $758K | Sell |
37,311
-8,548
| -19% | -$175K | 0.01% | 257 |
|
|
2024
Q2 | $1.04M | Buy |
45,859
+7,545
| +20% | +$198K | 0.01% | 217 |
|
|
2024
Q1 | $1.01M | Hold |
38,314
| – | – | 0.01% | 217 |
|
|
2023
Q4 | $1.21M | Hold |
38,314
| – | – | 0.01% | 197 |
|
|
2023
Q3 | $1.07M | Hold |
38,314
| – | – | 0.01% | 192 |
|
|
2023
Q2 | $1.41M | Sell |
38,314
-388
| -1% | -$11.8K | 0.02% | 180 |
|
|
2023
Q1 | $1.16M | Sell |
38,702
-768
| -2% | -$25.3K | 0.01% | 189 |
|
|
2022
Q4 | $1.21M | Sell |
39,470
-1,425
| -3% | -$42.8K | 0.01% | 178 |
|
|
2022
Q3 | $1.01M | Sell |
40,895
-160
| -0.4% | -$5.28K | 0.01% | 188 |
|
|
2022
Q2 | $1.31M | Sell |
41,055
-22,719
| -36% | -$836K | 0.02% | 168 |
|
|
2022
Q1 | $2.01M | Buy |
63,774
+113
| +0.2% | +$3.54K | 0.02% | 147 |
|
|
2021
Q4 | $2.14M | Buy |
63,661
+40
| +0.1% | +$1.25K | 0.02% | 150 |
|
|
2021
Q3 | $1.85M | Sell |
63,621
-1,000
| -2% | -$32.4K | 0.02% | 154 |
|
|
2021
Q2 | $2.25M | Buy |
64,621
+1,000
| +2% | +$33.1K | 0.03% | 147 |
|
|
2021
Q1 | $1.78M | Hold |
63,621
| – | – | 0.02% | 143 |
|
|
2020
Q4 | $1.58M | Sell |
63,621
-100
| -0.2% | -$2.38K | 0.02% | 135 |
|
|
2020
Q3 | $1.33M | Sell |
63,721
-140
| -0.2% | -$2.7K | 0.02% | 140 |
|
|
2020
Q2 | $980K | Hold |
63,861
| – | – | 0.02% | 156 |
|
|
2020
Q1 | $566K | Hold |
63,861
| – | – | 0.01% | 182 |
|
|
2019
Q4 | $1.16M | Hold |
63,861
| – | – | 0.02% | 162 |
|
|
2019
Q3 | $954K | Sell |
63,861
-81
| -0.1% | -$1.32K | 0.02% | 165 |
|
|
2019
Q2 | $1.53M | Buy |
63,942
+81
| +0.1% | +$2.39K | 0.03% | 137 |
|
|
2019
Q1 | $2.37M | Sell |
63,861
-494
| -0.8% | -$18K | 0.04% | 115 |
|
|
2018
Q4 | $1.82M | Buy |
64,355
+2,292
| +4% | +$72.5K | 0.04% | 124 |
|
|
2018
Q3 | $2.45M | Buy |
62,063
+239
| +0.4% | +$10.5K | 0.05% | 113 |
|
|
2018
Q2 | $2.74M | Sell |
61,824
-1,875
| -3% | -$93.3K | 0.05% | 102 |
|
|
2018
Q1 | $3.1M | Buy |
63,699
+1,415
| +2% | +$70.7K | 0.06% | 94 |
|
|
2017
Q4 | $3.12M | Sell |
62,284
-109
| -0.2% | -$5.71K | 0.06% | 93 |
|
|
2017
Q3 | $3.16M | Buy |
62,393
+318
| +0.5% | +$15K | 0.07% | 88 |
|
|
2017
Q2 | $2.35M | Buy |
62,075
+199
| +0.3% | +$7.85K | 0.05% | 98 |
|
|
2017
Q1 | $2.38M | Buy |
61,876
+3,479
| +6% | +$105K | 0.05% | 93 |
|
|
2016
Q4 | $1.29M | Sell |
58,397
-142
| -0.2% | -$2.92K | 0.03% | 119 |
|
|
2016
Q3 | $937K | Sell |
58,539
-238
| -0.4% | -$2.72K | 0.02% | 130 |
|
|
2016
Q2 | $484K | Sell |
58,777
-1,803
| -3% | -$16.1K | 0.01% | 168 |
|
|
2016
Q1 | $424K | Sell |
60,580
-104
| -0.2% | -$523 | 0.01% | 176 |
|
|
2015
Q4 | $325K | Sell |
60,684
-216,782
| -78% | -$1.39M | 0.01% | 198 |
|
|
2015
Q3 | $1.72M | Buy |
+277,466
| New | +$2.9M | 0.05% | 96 |
|
Other funds holding CC
CCPM
Haverford Trust Company's CC Position: Q2 2026 in Review
Haverford Trust Company increased its Chemours (CC) stake by 0.56% in Q2 2026, buying an estimated $3.43K and bringing the position to 26,898 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #295.
Haverford Trust Company first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $3.16M in Q3 2017. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Haverford Trust Company held 26,898 shares of Chemours worth $552K as of Q2 2026.
- Haverford Trust Company bought 150 Chemours shares in Q2 2026, an estimated $3.43K.
- Chemours made up ﹤0.01% of Haverford Trust Company's portfolio in Q2 2026, its #295 holding.
- Haverford Trust Company first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
- Haverford Trust Company's Chemours position peaked at $3.16M in Q3 2017.
- 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.